机构地区:[1]郑州大学附属肿瘤医院,河南省肿瘤医院中心实验室,450008 [2]郑州大学附属肿瘤医院,河南省肿瘤医院病理科,450008 [3]郑州大学附属肿瘤医院,河南省肿瘤医院癌症中心办公室,450008 [4]国家癌症中心,国家肿瘤临床医学研究中心,中国医学科学院北京协和医学院肿瘤医院流行病室,100021 [5]郑州大学附属肿瘤医院,河南省肿瘤医院妇瘤科,450008
出 处:《中华肿瘤杂志》2021年第10期1094-1099,共6页Chinese Journal of Oncology
基 金:国家自然科学基金(81502475);河南省科技攻关计划(192102310105);河南省高等学校重点科研项目计划(20A330005)。
摘 要:目的评价高危型人乳头状瘤病毒E6和E7(HR-HPV E6/E7)mRNA对意义不明的不典型鳞状细胞(ASCUS)人群的分流效果。方法选取2017年河南省信阳市罗山县312例宫颈癌筛查队列中液基细胞学检测结果为ASCUS的人群,所有ASCUS人群均行阴道镜活检和病理学检查,行HPV16或18(HPV16/18)、HR-HPV DNA和HPV E6/E7 mRNA检测,以病理学诊断为金标准,分别计算HPV E6/E7 mRNA、HR-HPV DNA、HPV16/18检测的灵敏度、特异度、阳性预测值(PPV)、阴性预测值(NPV)、转诊率及其95%CI。结果312例ASCUS人群的年龄为(52.6±7.3)岁。病理学诊断为正常的290例人群中,HPV E6/E7 mRNA检测出阳性例数为64例(22.1%),HR-HPV DNA检测出阳性例数为86(29.7%),HPV16/18检测阳性例数为19(6.6%);病理诊断为CIN 2(3例)和CIN 3级(6例)患者中,HPV E6/E7 mRNA和HR-HPV DNA检测的阳性例数均为3和6例。以CIN2+作为疾病终点指标时,HPV E6/E7 mRNA分流ASCUS人群的灵敏度、特异度、PPV、NPV、转诊率分别为100%(95%CI:72.3~100.0)、77.8%(95%CI:72.8~82.1)、13.0%(95%CI:7.2~22.3)、100%(95%CI:98.4~100.0)、24.7%。与HPV E6/E7 mRNA相比,HR-HPV DNA分流效果的灵敏度与HPV E6/E7 mRNA一致,但特异度低[70.2%(95%CI:64.8~75.1)],转诊率较高(32.1%),差异均有统计学意义(均P<0.05)。HPV16/18检测的特异度较高(93.4%,95%CI:90.0~95.7),但灵敏度低(30.0%,95%CI:10.8~60.3)。HPV E6/E7 mRNA检测在≥45岁年龄组和<45岁年龄组中分流的灵敏度均为100%,在≥45岁年龄组中分流的特异度为79.0%(95%CI:73.7~83.5),比<45岁年龄组的特异度(68.3%,95%CI:53.0~80.4)高,差异无统计学意义(P>0.05)。结论HPV E6/E7 mRNA检测对ASCUS人群的分流效果优于HR-HPV DNA和HPV16/18,其用于ASCUS人群的分流管理可以避免不必要的阴道镜转诊,同时降低宫颈病变的漏诊。Objective To evaluate the performance of high risk human papilloma virus(HR-HPV)E6/E7 mRNA in triaging women with atypical squamous cells of undetermined signification(ASCUS).Methods The ASCUS cohort determined by liquid-based cytology test in the cervical cancer screening queue in Luoshan County,Xinyang City,Henan Province 2017 were selected.The population underwent colposcopy biopsy and pathological tests,combined with HPV16 or 18(HPV16/18),HR-HPV DNA and HPV E6/E7 mRNA test.By using the pathological result as the gold standard,the sensitivity,specificity,positive predictor(PPV),negative prediction(NPV),referral rate and 95%confident interval(CI)of HPV E6/E7 mRNA,HR-HPV DNA,HPV16/18 were calculated,respectively.Results The average age of 312 ASCUS women was 52.6±7.3 years old.Among the 290 women diagnosed as normal by pathology,64(22.1%)were HPV E6/E7 mRNA positive,86(29.7%)were HR-HPV DNA positive,and 19(6.6%)were HPV16/18 positive.All of the cervical intraepithelial neoplasia(CIN)cases determined by pathology were both HPV E6/E7 mRNA and HR-HPV DNA positive.The sensitivity,specificity,PPV,NPV and referral rate of HPV E6/E7 mRNA for predicting CIN2+lesion in women with ASCUS were 100.0%(95%CI:72.3,100.0),77.8%(95%CI:72.8,82.1),13.0%(95%CI:7.2,22.3),100.0%(95%CI:98.4,100.0)and 24.7%.Compared with HPV E6/E7 mRNA,the sensitivity of HR-HPV DNA was similar with HPV E6/E7 mRNA,but with a lower specificity[70.2%(95%CI:64.8,75.1),P<0.05],a higher referral rate(32.1%,P<0.05);while HPV 16/18 had a high specificity(93.4%,95%CI:90.0,95.7)and a low sensitivity(30.0%,95%CI:10.8,60.3).Based on the age stratification by age 45,the sensitivity of HPV E6/E7 mRNA in both age groups was 100.0%.The specificity of HPV E6/E7 mRNA in group of≥45 years was a little higher than that in group of<45 years[79.0%(95%CI:73.7,83.5)versus 68.3%(95%CI:53.0,80.4)],but the difference was not statistically significant(P>0.05).Conclusions The ASCUS woman triaging effect of HPV E6/E7 mRNA detection is better than those of HR-HPV and HPV16/18 und
关 键 词:子宫颈肿瘤 人乳头状瘤病毒 E6和E7信使RNA 意义不明的不典型鳞状细胞 分流
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...